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Abstract 
The Alzheimer’s Disease is one of the most prevalent neurological disorders in our current 
society. The study of the genetic characteristics of every patient, makes possible the study of 
significant DNA variations in order to ease an early diagnosis, essential to stop the progression 
of the disorder. The problem is that the vast amount of available information makes necessary 
the use of a method designed to adequately store and manage this data in an optimal way for its 
exploitation. In this context, the Information Systems Engineering in general and the conceptual 
modelling techniques in particular, provide a suitable solution in order to determine which data 
is relevant and how to manage the corresponding information. With these fundamentals in mind, 
this paper introduces a particular example to bear the methodological treatment of the search, 
filter and load of genomic variations related to Alzheimer’s Disease for its later exploitation 
with clinical purposes. 
Keywords: Conceptual Modelling, Alzheimer’s Disease, Genomics, Information Systems. 
1. Introduction  
Personalized medicine has been gaining strength in the last years with the aim of specializing 
the care of patients improving their quality and expectancy of life. The study of the individuality 
of each patient can be addressed by reading (sequencing) its DNA. Thanks to the continuous 
progress achieved by genomic sequencing technologies it is possible to know the predisposition 
of developing certain diseases (phenotypes), what is called genotype-phenotype association. 
The huge amount of data that the continuous advances in sequencing technologies are 
generating, together with the heterogeneity and diversity of the existing data sources, makes the 
process of searching and identifying the relevant data, extremely hard. In this context, the study 
case cited in this article explains how relevant data have been obtained from a research about 
the phenotypical expression of Alzheimer’s Disease (AD), and how to manage them effectively 
and efficiently. By using appropriate information systems techniques and conceptual modelling 
techniques is the only way to move in the right direction, managing data correctly by providing 
i) a conceptual model to characterize relevant data, and  
ii) a sound method to search and identify those data that are considered clinically 
significant for the selected phenotype (AD in our case). 
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Data about genotype-phenotype associations are stored in specific repositories for its 
exploitation in population studies. What makes this domain so challenging is the huge amount 
of potentially valid data sources. In its last update, The NAR Online Molecular Biology 
Database Collection summarizes information about 1,737 repositories [1].  But not all of them 
are suitable to understand the genetic characteristics of a specific disease. As this process 
involves a great quantity of information, an efficient method is strictly required to obtain the 
relevant clinical data and their optimal management for its later exploitation. 
The method followed to select relevant data, explained in detail later, is based on an optimal 
database selection looking for the characteristics and goals of our work. A first selection was 
performed based on the scope, content and disease specificity of the databases. The data of 25 
databases storing information about Alzheimer, human DNA mutations and gene-disease 
associations were examined in order to evaluate its quality and to make a filtering with the 
purpose of excluding those repositories that do not add enough information. In the end, 4 
repositories were selected as reliable enough for the task at hand: Clinvar, Alzforum Mutations, 
DisGeNET, and ENSEMBL. 
By using these criteria, truthful and contrasted information of quality was obtained to be 
exploited in the context of the clinical diagnosis focused on AD. Making possible this clinical 
early diagnosis constitutes an extremely relevant social value of this work, as AD is a 
degenerative neuronal disorder, and stopping it “in time” becomes a key to the expectations of 
controlling the disease. This is only possible through accurate studies of its genotype-phenotype 
association, by managing the right data with the right method, what conforms the contribution 
reported in this work. 
Concretely, this paper introduces as essential contribution the process (together with the 
accumulated experience of its use) to determine how to search, identify and manage in a 
software platform for the genomic diagnosis, a set of relevant genomic variations for the AD. 
With this purpose in mind, after this introduction, in section 2 the problem is contextualized, 
introducing genome-based characteristics of the disease and analyzing in section 3 data 
repositories where information about its relevant genomic variations can be found. Section 4 
presents the conceptual model that plays an essential role to fix which are the relevant data to 
be considered. Then, in section 5 all the previous pieces are put together in the methodological 
work that was carried on and whose practical application experience the paper discusses. 
Finally, conclusions, future works and references complete the paper. 
2. Problem Statement   
Alzheimer’s Disease (AD) is a type of dementia that mainly affects to the capabilities and 
functionalities of the brain, decreasing them and avoiding the patient’s normal life 
development. 
 This type of dementia is characterized by affecting memory, followed by the language, 
thinking, orientation and behavior among other factors. Nowadays, there is not complete 
certainty of Alzheimer’s cause. Physiologically it is observable that when AD is advancing, the 
number of neurons is reduced, the accumulation of an abnormal protein (β-amyloid) increases 
and the brain starts to show injuries as senile plaques and neurofibrillary tangles [2]. These 
characteristics make clinical imaging and genome diagnosis essential to treat the disease: 
clinical imaging to detect visually the physiological, structural brain problems, and genomic 
diagnosis to identify accurately the genome variation sources of the abnormal protein 
production. 
The social value of adopting correct information systems design techniques to better 
diagnose and treating AD becomes obvious: it is the most common dementia, contributing in a 
60% to all of them. Considering the rise of the expectancy of life addressed by population 
during decades, it is possible to realize how serious this disease is in our current society. 
According to World Health Organization (WHO), 47 million people suffer from dementia and 
every year over 10 million more are registered [3]. 
The prevalence of AD in low and medium incomes countries is high, but in high income 
countries is also a disturbing topic and it has become a big social and economic problem for 
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health systems. That is because it is the main cause of dependency of old people and because 
the irreversibility of the disease, as nowadays it is only possible to reduce the speed of the 
disease’s advance. In economic terms, some research carried out in 2015 placed the social in 
US$ 818 000 million. WHO also estimates that from 60 years old, from 5 to 8% of the 
population will suffer dementia once in their life and the number of affected patients will grow 
up yearly in the next century. At this point, it is possible to understand the importance of the 
reduction of these significant statistical numbers. For that task it is important to know the 
problem to face. 
To close this brief section dedicated to understand the clinical working context, it is 
important to remark that AD can be classified, attending to the symptomatology showed, in 
early-onset and late-onset. 
• Early-onset AD: The disease starts to show symptoms before 65 years old 
(commonly around 50). This variant of the disease is less frequent than late-onset, 
however, genes which intervene in the development of the disease are well known 
nowadays [4]. This is why many studies talk about early-onset AD as Familial 
Alzheimer Disease. 
• Late-onset AD: Symptomatology is visible after 65 years old approximately. This 
variant of AD and the early-onset one, have been studied to determine that both 
could be hereditary. Nevertheless, the association between late-onset AD and the 
genes involved are not as studied as the early-onset ones. 
The genes affected in early-onset AD are well known. However, late-onset AD has not a 
wide and contrasted list of confirmed genes, so due to our strict reliability criteria for 
effectiveness data exploitation the work will be focused on different forms of early-onset AD 
disease and familial AD. The genes affected by this disease are three: 
• APP, responsible gene of the amyloid precursor protein synthesis [5]. 
• PSEN1 and PSEN2, which intervene in regulation and moderation of β-amyloid 
proteins [4, 14]. 
If we look at the diversity of the data that the genomic characterization of the studied 
disease has, it is clear that we face an extremely complex data management problem, where the 
diversity in the data sources, the data heterogeneity, redundancies and inconsistencies, make 
strictly required the use of sound Information System-based approaches. It has been surprising 
for us to detect that this too often is not the case in applied bioinformatics, where ad-hoc, 
solution-space oriented results are much more common than a careful conceptual-based data 
analysis. This damages the effectiveness of this particular complex working domain, and it is 
indeed the problem that we want to better solve with this work.  
The first step for the methodological support that we want to characterize must be to select 
adequately the relevant data sources to obtain information from. Let’s analyze how the problem 
has been solved for the Alzheimer case. 
3. An overview of Alzheimer-related Data Sources  
Nowadays, many repositories with genomic information are publicly available, but finding 
repositories where contrasted direct associations between variations and diseases (the genotype-
phenotype connection) may be quite more difficult. The work to be done is strongly dependent 
on this information, so it is important to know the sources where relevant information for the 
research process is going to be found. Through the method that we present in next section, up 
to 25 possible repositories were examined, and only 4 of them were finally selected: Alzforum 
Mutations, DisGeNET, ClinVar and ENSEMBL. 
Why have we selected those 4 public data sources commented above and not others? 
DisGeNET is one of the biggest public collections of genes and variations linked to human 
diseases. Thus, it is possible to select the disease and through a list of genes it is possible to find 
those which are relevant for this study and analyze, variation by variation, the gen associated 
to the chosen disease. The information offered can be contrasted by accessing to its associated 
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bibliography. Moreover, it is possible to know the quality of the genotype-phenotype relation 
through a score which introduces how strong or weak is this link [6]. 
Maybe ClinVar is the most well-known repository of this work. ClinVar is a freely 
accessible, public archive of reports of the relationships among human variations and 
phenotypes, with supporting evidence. It belongs to National Center for Biotechnology 
Information, what makes its control and quality more regulated [7]. 
Finally, ENSEMBL presents itself as a “genome browser for vertebrate genomes that 
supports research in comparative genomics, evolution, and sequence variation and 
transcriptional regulation”. It owns a specific browser which filters information from the 
repository and makes the information appear more visual and useful [8]. 
These public data repositories can be complemented with others specialized in a particular 
disease that can provide additional valuable data. Indeed, Alzforum is a webpage where a lot 
of contrasted information about Alzheimer is exposed. It contains various repositories, where 
the Mutations database can be found [9]. Mutations is the only specific repository about AD 
that is also used in this article. Its goal is to introduce a list of variations about specific genes 
and relate them to clinical, neuropathological characteristics and functional effects. This 
repository was selected as it works on the specific genes APP, PSEN1, PSEN2 and MAPT, 
being three of them the main genes studied in this article. 
In next section we present the conceptual model that plays an essential role to identify the 
relevant data to be considered from each selected data source. 
4. Conceptual Model  
Conceptual models let conceptualize a specific domain in order to ease its understanding. 
Corresponding relational schemas (if the represented database of the conceptual model is 
relational) provide an operational base which allows a more efficient and correct data 
management. Due to the huge amount of data that must be stored and managed when we talk 
about disease genomic diagnosis, a precise conceptual model plays an essential role to represent 
the complexity of the genomic variations, their association with the phenotypes and the way to 
structure the information. 
Fig 1. introduces the conceptual model that determines what relevant data attributes must 
be captured from the selected data sources. The selection of data is then conceptual model-
guided, and this is a basic characteristic of the method presented in the next section. The 
attributes of the conceptual model fix which data must be captured from the corresponding data 
sources. Once the mappings between conceptual model attributes and their associated 
counterparts in the data sources are specified, the method is ready to accomplish a process of 





Fig. 1. View of the Human Genome Conceptual Model used in this work [10]. 
This Conceptual Model itself is not a contribution of this work; It is part of the Human 
Genome Conceptual Model designed by the PROS Research Center in UPV.  It is currently in 
its 3rd version (HGCM v3) and (according to [10]) it maintains the essential genome 
information through its 5 main views (structure, transcription, variations, chromosome and 
metabolic routes). The contribution of this paper is how the Conceptual Model becomes the key 
component of the method presented next, by determining what information from the selected 
data sources must be captured and loaded in the database. 
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5. SILE: The Method for the Alzheimer’s Disease Research 
As mentioned before in this paper, genomic diagnosis requires a truthful and reliable high 
quality data [11]. Thus, a set of filters which provide desired characteristics for our data must 
be defined. In next section, the sequence of actions carried out to make effective and efficient 
the filtering task, is exposed, with the aim of obtaining a curated dataset that includes the right 
variations for clinical purposes. This series of steps is based on the SILE method, whose 
application for the AD case is reported here as a proof of concept. 
The SILE method is proposed as a solution to the bottleneck that currently affects the 
identification of relevant DNA variations with clinical purposes. The process is performed by 
experts in the field who extracts the information from the available literature by reading 
hundreds of studies. This constitutes a high effort and the use of public databases is not widely 
extended due to the huge number of repositories and the increasing difficulty of integrating the 
heterogeneous data they store. SILE provides a systematic method to extract knowledge from 
these repositories based on well-defined quality criteria that assure the reliability of the results. 
There are some proposals which integrate information from multiple repositories or extract 
data from literature, such as DisGeNet1, SNPedia2 or LitVar3, but they don’t take into account 
the veracity or relevancy of the information managed, a key aspect when the information is 
going to be used in a clinical environment. 
The SILE method goal is to accomplish the optimal information identification and its 
efficient load in the Human Genome Database. The method follows 4 essential steps named 
Search, Identification, Load and Exploitation. Each SILE’s step is necessary to ensure the right 
application of the next step. 
5.1. Search 
The Search step is a process intended to select certain databases and sources that provide 
reliable quality information, i.e., it is addressed directly to data sources. As we have advanced 
in section 3, AD has specific disease repositories (as Alzforum Mutations), but most of the 
information is located in general databases about genotype-phenotype variations which add 
extra knowledge. 
In the AD case, the Search step started with a list of 25 possible repositories, 21 of which 
were discarded by the application of filters, resulting in the final selection of 4 data sources. 
The list of filters is summarized in Table 1. 
Table 1. Set of filter used to select reliable databases. 
 Filter description 
Trustworthiness The information must be reviewed by a group of experts in the field. 
Reputation The data source must be supported by any research center, association or 
institute with national or international relevance. 
Timeliness There must be date stamps about when data were entered as well as when last 
modified. 
Currency The database must be active (less than 1 year from the last update). 
Availability The information must be public and freely accessible. 
Usefulness The information must be relevant and useful for the task at hand. 
 
One of the first selected databases was Mutations from Alzforum because of its AD 
specificity. The amount of data offered by the database about AD was bigger due to the main 
goal of the repository. Moreover, data curation is provided by a team with backgrounds in 
science journalism, information technology, design, and data science. Together with a 






distinguished Scientific Advisory Board and the active participation of a global network of 
scientists, they produce high quality and rigorous data. This argument is supported by the 
proportion of articles which references each variation. 
Another useful repository is DisGeNET. As also mentioned in Section 3, this source is 
specialized in the genotype-phenotype relation in human diseases. It means that with a simple 
search in the database about AD a great amount of data about the disease can be retrieved. The 
information is organized attending to curation levels where we can distinguish curated data 
from other sources (ClinVar, UniProt, PsyGeNET, Orphanet…), animal models and a wide 
variety of information about variations extracted through software directly from the literature. 
Data mining can be done in many ways but the easiest one is through its interface which 
provides a disease browser where finding associated genes, and variations is possible. The 
added value of DisGeNET is the classification of variations according to a score. In this 
repository, information about updates of the database and its information can be easily found. 
ClinVar also was selected for the task as it offers reports about relations between human 
genomic variations and phenotypes with demonstrated evidence. Moreover, ClinVar eases 
access to and communication about the relationships asserted between human variation and 
observed health status, and the history of that interpretation. This repository is reviewed weekly 
and big updates are released monthly, so its updating tax is higher than other repositories. 
Interpretation of variations is not carried out by ClinVar, but the curation is carried out by 
experts who propose guides and practices to control the submission of results to the database. 
The quality classification of curation is through the number of submitters attending 
coincidences or discrepancies. For that task, it is used a star rank based on a hierarchy where 1 
star is less curated than the maximum of 4 stars. 
Finally, Ensembl database was chosen because it is a repository specialized in the human 
genome. Among all available databases, Ensembl has the best interface to filter information 
and select the required characteristics to ensure quality data according to the conceptual model. 
The database provides information and detailed dates about future patches which can modify 
the database and its data. As mentioned before, it owns an advanced browser to find variations 
associated with AD and to obtain the needed information for the Load process. 
5.2. Identification 
Once the data sources have been selected, the Identification step starts. At this point, the 
information must be extracted in order to be analyzed later to obtain a curated dataset for the 
exploitation. The result is a candidate set of relevant variations, that must follow a process of 
filtering in order to determine the final, reduced subset of totally reliable data. Data reliability 
is essential considering its clinical, diagnosis-oriented purpose. This part of the global method 
has the higher cost as it depends on the application of different filters that we detail below. 
It is important to remark that the “Identification” step is strictly linked to the conceptual 
model. Inside the model, there are many attributes for a variation. In this work, an analysis of 
the essential attributes that a variation must have was carried out in order to determine what a 
complete variation is and how to solve the problem in a real case. In Table 2 the set of 
characteristics selected from the Conceptual Model is shown. Each attribute in the conceptual 
model has a counterpart attribute coming from the corresponding selected data source. In the 
repositories that support this study, different values for AD variation attributes were found. As 
it happens, it was firstly decided to select all variations which show up the following 
characteristics: 
1. The criteria used to stablish the association between the variation and the disease 
must be provided (e.g. at least one star in ClinVar). 
2. The condition or phenotype must be showed. 
3. The variations must be identified by using the rs identifier (i.e. rs2918276). 
4. They must have clinical significance. 
In that way, variations which does not comply these requirements would be discarded and 
the final dataset would be more valid. Starting by this criteria, 205 valid variations were 
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obtained from Alzforum Mutations, 97 from DisGeNET, 110 from Clinvar and 59 from 
Ensembl. The result was 471 variations in our initial dataset where other filters must be applied. 
Table 2. Correspondence between the attributes of the HGCM and the attributes provided by each 
database. 
 ClinVar Ensembl DisGeNet AlzForum 
CHROMOSOME_NAME Genomic 
location 






DBSNP_IDENTIFIER dbSNP Archive 
dbSNP 
dbSNP dbSNP ID 
STRAND  Location   
POSITION_START HGVS VCF Position Position 
REF_SEQUENCE HGVS VCF Alleles Position 
ALT_SEQUENCE HGVS VCF Alleles Position 
SYMBOL Affected 
gene 






PHENOTYPE_NAME Condition(s) Phenotype Disease Clinical 
Phenotype 
PUBMED_ID Citations PMID PMID Citation 
 
At this point, a new filtering step was applied to ensure even more the veracity of the 
dataset, discarding every variation which has no citations or references to studies where the 
information could be contrasted. After applying this filter, the final set was stablished in 176 
variations. With this final high quality dataset generated, and having the connection between 
attributes of the conceptual model and attributes of the data sources precisely specified, the 
method was ready to move to the next stage intended to load the generated data in a specific 
database. 
5.3. Load 
In this step of the process, the extracted dataset of AD variations was loaded in the human 
genome database (HGDB), created for clinical purposes oriented to the precision medicine. The 
concrete database management system is completely independent of the conceptual model. In 
our case study the HGDB is a relational database implemented in MySQL. Nevertheless, the 
model could have been implemented in any other type of database by making the corresponding 
transformation from the conceptual schema to the logical and physical ones. This 
transformation is out of the scope of this work, but it is important to emphasize that the SILE 
method is totally “agnostic” with respect to any selection of database technology. There is 
indeed a transformation using a Graph Database (Neo4J) being currently under developed in 
our research team. 
The reported work is in any case an illustrative example of the method to find and organize 
clinical genomic data from repositories with the purpose of exploiting them efficiently. The 
goal of this “Load” step is just to fix the structural organization of the information inside the 
database, in a conceptual model-based process. 
As said before, Conceptual Modelling is important in the Identification process to know 
which attributes of the repository will be useful; nevertheless, it is in the Load stage where they 
are organized to obtain a working solution, and to make the data accessibility intuitive for the 




Fig. 2. Example of loading 8 variations with its identifiers in the database for the gene, the identifiers 
for the version of the database, the identifier of the variation in its corresponding database and its 
clinical importance. 
Fig. 2 shows how variations can be accessed and managed when they are available through 
a functional database support. The precise link between conceptual model, genome data sources 
and selected databases assures the understanding of the final software product where data are 
to be interpreted and managed in real clinical settings. 
5.4. Exploitation 
This is the final step of the developed example of this project. With the data load completed, 
the subsequent database is the core of the software platform intended to make possible the 
genomic diagnosis by professionals. The selected tool is called GenesLove.me [12] and its 
purpose is to analyze the information obtained from a patient sample and determine if there are 
variations associated to a certain disease, according to the data stored in the database. 
6. Results and Discussion 
The final result of this process consists on a dataset, whose quality, veracity and validity are 
assessed by the methodological background provided by the SILE method. Data are loaded in 
a database and are ready to be used in an effective precision medicine scope. The reported work 
shows up the main objective: to demonstrate the current difficulty of the treatment of genomic 
data related to a characteristic disease such as the Alzheimer’s Disease is. The reach of the 
desired goal of the study –the set of AD-related relevant variations-, is a complex task. To fix 
a concrete set of requirements has been essential to exclude those variations that could not fit 
the required quality criteria. This set of quality requirements is dynamic: potential changes are 
to be considered to adapt the filtering process to the information that is continuously appearing 
in the analyzed domain. 
During the initial process of searching, most of the databases were excluded as they did not 
add precise information, i.e. they were giving references to other repositories, generating data 
duplication when different sources really referred to the same result. That is a good example of 
the need to specify strict filters to avoid future quality compromises. 
During the identification process, most of the difficulties were found in relation to the 
acceptation or rejection of variations. Genomic data repositories are very different. The lack of 
common criteria to represent the same information generates the existence of different attributes 
with a wide variety of nomenclatures. This makes the Identification process more difficult, and 
makes automation become complicated, requiring an intense handwork by the researcher. 
Additionally, non-existing information from the conceptual model has to be managed, finding 
out the right data sources where the lacking information could be recovered. The use of the 
conceptual model provides the needed semantic reference to identify the required data, and the 
methodological background provided by SILE structures the process to be followed to conform 
a correct, genomic IS management. 
More examples can be discussed here. Different repositories may contain different amounts 
of information, sometimes even distinct. In the same way that information about updates have 
been found for ClinVar or ENSEMBL, Mutations did not show any information about it. 
Talking about DisGeNET, it was necessary the interpretation of all the bibliographic references 
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in order to extrapolate the clinical significance of each variation (pathogenic, benign or 
protective). 
Another important aspect related to the identification process was the presence of 
contradictory information. Variations which show up a determined clinical significance in a 
specific database could introduce the opposite result in a different repository. An example of 
that is variation rs140501902, pathogenic for AD in DisGeNET but in Alzforum Mutations it 
appears as not pathogenic. Data discrepancies implies in our method an automatic discard due 
to the doubts in the veracity of the result, although it is important to remark that the dynamic 
property of the selected criteria makes a research option to select variation fulfilling or not 
fulfilling any particular criteria: each individual SILE execution generates a result that is fully 
dependent on the selected criteria. 
Finally, it is worth to emphasize the absence of fully contrasted information about AD. A 
great quantity of data existed in the diverse repositories which, a priori, could suggest that the 
study will be very complete. Nevertheless, when quality filters were applied, results decreased 
rapidly and in a significant way, what shows that a very relevant part of the data was associated 
with not valid information for the exploitation process. 
7. Conclusions and Future Work 
In the scope of the modern, genomic-based Medicine of Precision, an effective and efficient 
information systems development strategy is essential. This paper shows how to face this 
problem for a concrete clinical domain –the Alzheimer’s Disease-, by using a method 
conceptual model-centered to characterize and structure how relevant data sources must be 
selected, how to obtain from them a set of candidate variations that are significant in clinical 
terms and how to filter them in order to refine the set to obtain the required set of valid 
variations. 
The role of the conceptual model is to precise the information that must be captured, 
defining the mappings between the attributes of the model and their corresponding genomic 
data source counterpart. The automation of this essential part of the process is now under study, 
with the goal of designing a software platform based on a database whose data could be updated 
automatically by developing the corresponding access mechanisms with the data sources. 
How the method was applied for the AD case is reported in the work. One of the most 
relevant results is the selected set of variants, that have been loaded in a data-base that is used 
by a genomic diagnosis software platform (GenesLove.Me [12]) that can now include in its 
catalog of clinical services the diagnosis of this disease. 
As the application of the SILE method in different diseases can have different properties, 
it is our next step to apply the method to other disease in order to compare the obtained results, 
analyzing commonalities and differences of the process, and adapting the quality criteria used 
by the method to the particular information that is available for the case under study. The final 
attempt is to propose a holistic, universal method that could be applied to manage correctly 
Genome Information Systems for the challenging Medicine of Precision. 
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